SC 13D/A

NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A(

Company: Trevi Therapeutics, Inc.
Filed: May 21, 2024
Accession Number: 0001072613-24-000518

View Document ↗ View on SEC.gov ↗